drugs News & Analysis
3 articles
Market Mood
Absci Corporation (ABSI) Shares Trade at $7.27 Amid AI Drug Development
As of June 15, Absci Corporation's (ABSI) shares were trading at $7.27. The company is engaged in AI-driven drug discovery, with its lead program, ABS-201, targeting androgenetic alopecia and currently in human clinical trials. Early safety data from the HEADLINE trial has built investor confidence in the program's potential. Absci's platform is aligned with a shift in the industry towards faster drug development, positioning it favorably for future growth in multiple therapeutic areas, including endometriosis.
Read More
BBC Investigation Reveals Drug Sales in High Street Mini-Marts
A BBC investigation uncovered drug sales, including 3.5g of cannabis for £30, at mini-marts in the West Midlands. Undercover researchers recorded transactions at Cradley Market, where a worker offered various drugs. The UK government is collaborating with police and the National Crime Agency (NCA) to combat such criminal activities. West Midlands Police stated their commitment to address complaints related to illegal drug sales and anti-social behavior.
Read More
Eli Lilly (LLY) GLP-1 Pill Approved: Launching Foundayo for Weight Loss
Eli Lilly's (LLY) GLP-1 pill, Foundayo, has received FDA approval and will begin shipping via LillyDirect, available in pharmacies
Read More